EDGAR·FLOW

BioCardia, Inc. — Form 8-K

Filed November 20, 2026 · analyzed by the 8-K Agent
8-K ▼ Likely negative significance 72/100
What the filing says
BioCardia (market cap ~$9.7M) filed an 8-K on November 20, 2026 reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The filing provides no specific details on which exchange rule was violated, the timeline for delisting, or which exchange it may transfer to. This is a material governance event for a micro-cap company but lacks concrete financial or operational specifics in the extracted text.
Why this rating

Delisting threat is serious for a $9.7M company—jeopardizes liquidity and investor access. However, lack of detail on severity, timeline, or remediation path prevents higher scoring. Significant relative to company size.

Extracted items
Price action (we called it negative)
before filing · preread
$0.79
at our read
pending
+10 min
pending
+30 min
pending
+1 hr
pending
+4 hrs
pending

Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →

View original filing on SEC.gov ↗ BCDA · stock on Yahoo Finance ↗

See more from November 20, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.